STAGE III NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE III NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE III NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost lung cancer treatment completion
Disease control Recruiting nowThis study tests whether a faster, more precise radiation plan combined with standard chemotherapy and an immunotherapy drug (durvalumab) can help more people with stage III lung cancer finish their treatment. About 110 adults with unresectable lung cancer will be randomly assign…
Matched conditions: STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: TheraOp • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC
-
Blood test may personalize lung cancer therapy
Disease control Recruiting nowThis study tests whether a simple blood test (ctDNA) can help doctors decide if adding chemotherapy to the immunotherapy drug cemiplimab works better for advanced lung cancer. About 63 people with stage IV or stage IIIB/C non-small cell lung cancer that hasn't been treated before…
Matched conditions: STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 03, 2026 12:04 UTC